Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
245.07
+3.02 (1.25%)
Jan 21, 2025, 4:00 PM EST - Market closed
Cencora Employees
Cencora had 46,000 employees as of September 30, 2023. The number of employees increased by 2,000 or 4.55% compared to the previous year.
Employees
46,000
Change (1Y)
2,000
Growth (1Y)
4.55%
Revenue / Employee
$6,390,404
Profits / Employee
$32,807
Market Cap
47.37B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 46,000 | 2,000 | 4.55% |
Sep 30, 2022 | 44,000 | 2,000 | 4.76% |
Sep 30, 2021 | 42,000 | 20,000 | 90.91% |
Sep 30, 2020 | 22,000 | 0 | - |
Sep 30, 2019 | 22,000 | 1,000 | 4.76% |
Sep 30, 2018 | 21,000 | 1,000 | 5.00% |
Sep 30, 2017 | 20,000 | 1,000 | 5.26% |
Sep 30, 2016 | 19,000 | 1,500 | 8.57% |
Sep 30, 2015 | 17,500 | 3,500 | 25.00% |
Sep 30, 2014 | 14,000 | 1,000 | 7.69% |
Sep 30, 2013 | 13,000 | -1,500 | -10.34% |
Sep 30, 2012 | 14,500 | 4,200 | 40.78% |
Sep 30, 2011 | 10,300 | 300 | 3.00% |
Sep 30, 2010 | 10,000 | -300 | -2.91% |
Sep 30, 2009 | 10,300 | -600 | -5.50% |
Sep 30, 2008 | 10,900 | -400 | -3.54% |
Sep 30, 2007 | 11,300 | -3,400 | -23.13% |
Sep 30, 2006 | 14,700 | 1,300 | 9.70% |
Sep 30, 2005 | 13,400 | -700 | -4.96% |
Sep 30, 2004 | 14,100 | -700 | -4.73% |
Sep 30, 2003 | 14,800 | 1,100 | 8.03% |
Sep 30, 2002 | 13,700 | 0 | - |
Sep 30, 2001 | 13,700 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
COR News
- 8 days ago - Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth - Seeking Alpha
- 13 days ago - Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release - Business Wire
- 19 days ago - Cencora raises annual profit forecast - Reuters
- 19 days ago - Cencora Completes Acquisition of Retina Consultants of America - Business Wire
- 6 weeks ago - Cencora Closes $1.8 Billion Senior Notes Offering - Business Wire
- 6 weeks ago - Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers - Business Wire
- 6 weeks ago - Cencora: Competitive Advantages Defined - Seeking Alpha
- 7 weeks ago - Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035 - Business Wire